Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001144204-12-039491
Filing Date
2012-07-16
Accepted
2012-07-16 06:02:26
Documents
4
Effectiveness Date
2012-07-16

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT v318601_s-8.htm S-8 78031
2 EXHIBIT 5.1 v318601_ex5-1.htm EX-5.1 7434
3 EXHIBIT 23.2 v318601_ex23-2.htm EX-23.2 3421
4 GRAPHIC logo.jpg GRAPHIC 5857
  Complete submission text file 0001144204-12-039491.txt   98326
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-182677 | Film No.: 12962635
SIC: 2836 Biological Products, (No Diagnostic Substances)